Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ONCOSEC MEDICAL IncONCS · Entity 117092 | Director | January 02, 2019 | January 04, 2019 |
| Skye Bioscience, Inc.SKYE · Entity 8098 | Director · Chief Executive Officer | August 07, 2026 | August 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ONCOSEC MEDICAL Inc
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.66 · Expires 2029-01-02 | Direct | 50,000 |
Reported balance
After 2019-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 50,000 · Balance 50,000 F1: This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan.
Skye Bioscience, Inc.
Report date August 07, 2026 · Filed August 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,419,823 |
Reported balance
After 2026-08-07 transaction · row 1
1 source rowRow 1 · 2026-08-07 · Grant · Acquired 1,090,000 · Balance 1,419,823 F1: Represents a restricted stock unit ("RSU") award that will vest on August 31, 2027 subject to (a) the Reporting Person's continued employment through such date or (b) the termination of the Reporting Person's employment by the Company for any reason other than For Cause, By Death or By Disability (each, as defined in the Reporting Person's Executive Employment Agreement), provided the Reporting Person executes and does not revoke the release agreement appended to the Reporting Person's Executive Employment Agreement. F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| Common StockSEC Table I · non-derivative | IndirectTrust | 9,343 |
Reported balance
Holding disclosure · report date 2026-08-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 9,343 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award that will vest on August 31, 2027 subject to (a) the Reporting Person's continued employment through such date or (b) the termination of the Reporting Person's employment by the Company for any reason other than For Cause, By Death or By Disability (each, as defined in the Reporting Person's Executive Employment Agreement), provided the Reporting Person executes and does not revoke the release agreement appended to the Reporting Person's Executive Employment Agreement.
F2: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Arch Therapeutics, Inc.
Report date November 10, 2022 · Filed November 11, 2022
Section 16 reporting ended · disclosed 2021-10-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.04 · Expires 2032-11-10 | Direct | 250,000 |
Reported balance
After 2022-11-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-11-10 · Grant · Acquired 250,000 · Balance 250,000 F1: The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 12 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the "Plan"). The option shall vest equally on each of the first 12 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2019 Filed Dec 23, 2019 13:32 UTC | Arch Therapeutics, Inc. ARTH · Entity 109849 | GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $0.23 | $0.00 |
DisclosureSEC source: 0001104659-19-075320 · tm1926824-2_4.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-12-19 F1 · derivative.exercise_date: Of the Shares subject to the Option, 1/12 shall vest on each of the next twelve (12) monthly anniversaries of the Vesting Commencement Date. In the event of a Change of Control (as such term is defined in the Plan) all Options subject to this grant will immediately vest. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:01 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.66 | $0.00 |
DisclosureSEC source: 0001493152-19-000205 · ownership.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2029-01-02 F1 · shares: This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 16:17 UTC | Skye Bioscience, Inc. NMUS · Entity 8098 | GrantDirector Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $0.31 | $0.00 |
DisclosureSEC source: 0001209191-18-054866 · doc4.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-10-10 F1 · derivative.exercise_date: The option will vest in equal monthly installments over a one-year period commencing on the date of grant. Read SEC document |
| July 19, 2018 Filed Jul 20, 2018 16:03 UTC | Arch Therapeutics, Inc. ARTH · Entity 109849 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $0.43 | $0.00 |
DisclosureSEC source: 0001144204-18-039093 · tv498877_4.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2028-07-18 F1 · derivative.exercise_date: Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date. Read SEC document |
| July 05, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 45,785 | $1.31 | $60,069.92 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 14 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,262 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 32,000 | $1.31 | $41,984.00 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 15 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,262 Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 13,785 | $1.31 | $18,085.92 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 14 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,262 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 29, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 5,401 | $1.38 | $7,453.38 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 13 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,047 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 29, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 5,401 | $1.38 | $7,453.38 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 13 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,047 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 28, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 7,882 | $1.40 | $11,042.68 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 12 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,448 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 28, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 7,882 | $1.40 | $11,042.68 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 12 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 536,448 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 27, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 17,480 | $1.37 | $24,017.52 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 11 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,330 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 27, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 17,480 | $1.37 | $24,017.52 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 11 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,330 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 26, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 23,820 | $1.40 | $33,300.36 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 10 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,810 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 26, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 23,820 | $1.40 | $33,300.36 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 10 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,810 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 25, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 1,021 | $1.41 | $1,434.51 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 9 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,630 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 25, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 1,021 | $1.41 | $1,434.51 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 9 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,630 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 22, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 14,976 | $1.42 | $21,235.97 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 8 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,651 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 22, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 14,976 | $1.42 | $21,235.97 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 8 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,651 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 21, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 11,035 | $1.40 | $15,460.04 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 7 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,627 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 21, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 11,035 | $1.40 | $15,460.04 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 7 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,627 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 20, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 55,585 | $1.42 | $79,041.87 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 6 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,662 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 20, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 55,585 | $1.42 | $79,041.87 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 6 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 612,662 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 19, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 9,310 | $1.36 | $12,698.84 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 5 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,247 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 19, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 9,310 | $1.36 | $12,698.84 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 5 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,247 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 18, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 28,145 | $1.39 | $39,008.97 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 4 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,557 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 18, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | SaleCommon Stock | 28,145 | $1.39 | $39,008.97 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 4 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 677,557 F2 · security: Sale to cover taxes on restricted stock unit vesting. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · derivative · entry 17 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2018-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · derivative · entry 16 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2020-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · derivative · entry 15 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2019-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 3 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 2 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 6, 2018 16:40 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009769 · ownership.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · derivative · entry 18 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,000 shares Expires 2018-11-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · derivative · entry 17 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2020-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · derivative · entry 16 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2019-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 3 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 150,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 2 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| June 15, 2018 Filed Jul 9, 2018 21:11 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Exercise / conversionCommon Stock | 125,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-18-009835 · ownership.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 355,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 17:43 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantRestricted Stock Units · Derivative | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-001772 · form4.xml · derivative · entry 2 DHILLON PUNIT · CIK 0001425052 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,583 Underlying: Common Stock · 200,000 shares Expires 2028-02-08 F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F3 · derivative.exercise_date: Pursuant to the Amended and Restated Executive Employment Agreement, dated November 7, 2017, between OncoSec Medical Incorporated and Punit Dhillon, the restricted stock units vest in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan; however, pursuant to a subsequent lock-up agreement related to OncoSec's financing, dated February 1, 2018, vesting is deferred until May 7, 2018. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 17:43 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantOption to Purchase Common Stock · Derivative | 300,000 | $1.64 Strike: $1.64 | $492,000.00 |
DisclosureSEC source: 0001493152-18-001772 · form4.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114,583 Underlying: Common Stock · 300,000 shares Expires 2028-02-08 F1 · derivative.exercise_date: 25% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. Read SEC document |
| February 06, 2018 Filed Feb 6, 2018 14:57 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | PurchaseCommon Stock | 3,000 | $0.88 | $2,640.00 |
DisclosureSEC source: 0001493152-18-001525 · form4.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dhillon Living Trust dated May 24, 2017 Disclosed balance after: 230,702 F1 · kind: The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan F2 · ownership.nature: The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2017 Read SEC document |
| February 06, 2018 Filed Jul 6, 2018 16:05 UTC Amendment | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantCommon Stock | 3,000 | $0.88 | $2,640.00 |
DisclosureSEC source: 0001493152-18-009761 · ownership.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,702 F1 · kind: This amended Form 4 is being filed to correctly reflect the Reporting Person's exempt acquisition of shares pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan. The Reporting Person acquired the shares pursuant to the plan on February 1, 2018, and subsequently transferred the shares to a living trust. The original Form 4 filed on February 6 used an incorrect transaction code that indicated they were acquired through an open market purchase. Read SEC document |
| January 12, 2018 Filed Jan 17, 2018 16:30 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001493152-18-000657 · form4-dhillon.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 814,583 Underlying: Common Stock · 250,000 shares Expires 2027-11-04 F1 · derivative.exercise_price: OncoSec's (ONCS) stock closing price was $1.32 on November 4, 2017. F2 · date: The Stock Options to purchase 250,000 shares of common stock of the issuer were approved by OncoSec's Board of Directors on November 4, 2017 ("Grant Date") and the contingency restriction was removed after OncoSec's Annual Stockholders Meeting held on January 12, 2018. F2 · shares: The Stock Options to purchase 250,000 shares of common stock of the issuer were approved by OncoSec's Board of Directors on November 4, 2017 ("Grant Date") and the contingency restriction was removed after OncoSec's Annual Stockholders Meeting held on January 12, 2018. F3 · derivative.exercise_date: 25% vested on January 12, 2018, and the remaining 75% are vesting in 36 equal monthly increments, which began on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 17:14 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | PurchaseCommon Stock | 3,000 | $0.88 | $2,640.00 |
DisclosureSEC source: 0001493152-17-008406 · form4.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dhillon Living Trust dated May 24, 2016 Disclosed balance after: 227,702 F1 · kind: The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan F2 · ownership.nature: The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2016 Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 21:37 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantOption to Purchase Common Stock · Derivative | 150,000 | $1.34 Strike: $1.34 | $201,000.00 |
DisclosureSEC source: 0001493152-17-003329 · form4.xml · derivative · entry 2 DHILLON PUNIT · CIK 0001425052 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 564,583 Underlying: Common Stock · 150,000 shares Expires 2027-03-29 F3 · derivative.exercise_date: 25% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 21:37 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantRestricted Stock Units · Derivative | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-003329 · form4.xml · derivative · entry 1 DHILLON PUNIT · CIK 0001425052 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 150,000 shares Expires 2020-03-29 F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit. F2 · derivative.exercise_date: 100% of the restricted stock units are scheduled to vest on March 29, 2020, assuming continued employment and/or service through the applicable vesting date. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:43 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | PurchaseCommon Stock | 3,000 | $0.99 | $2,970.00 |
DisclosureSEC source: 0001493152-17-001056 · form4.xml · nonDerivative · entry 1 DHILLON PUNIT · CIK 0001425052 · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Dhillon Living Trust dated May 24, 2016 Disclosed balance after: 224,702 F1 · kind: The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan F2 · ownership.nature: The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2016 Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 17:25 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | GrantEmployee Stock Option (right to buy) · Derivative | 314,583 | Not disclosed Strike: $1.29 | Not disclosed |
DisclosureSEC source: 0001493152-16-015977 · form4.xml · derivative · entry 6 DHILLON PUNIT · CIK 0001425052 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,583 Underlying: Common Stock · 314,583 shares Expires 2026-12-14 F1 · security: These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option. F3 · price: On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 25000 shares (previously granted on April 25, 2012), 12500 shares (previously granted on February 8, 2013), 100000 shares (previously granted on March 7, 2014), 25000 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 314583 shares of common stock with an exercise price of $1.29 per share. F9 · derivative.exercise_date: The stock options granted on December 14, 2016 will vest on the following schedule: 25% vested on the grant date; 1/36th of the remaining 75% will vest on each of the 36 subsequent monthly anniversaries of the grant date. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 17:25 UTC | ONCOSEC MEDICAL Inc ONCS · Entity 117092 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 500,000 | Not disclosed Strike: $5.76 | Not disclosed |
DisclosureSEC source: 0001493152-16-015977 · form4.xml · derivative · entry 5 DHILLON PUNIT · CIK 0001425052 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500,000 shares Expires 2025-08-21 F1 · security: These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option. F3 · price: On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 25000 shares (previously granted on April 25, 2012), 12500 shares (previously granted on February 8, 2013), 100000 shares (previously granted on March 7, 2014), 25000 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 314583 shares of common stock with an exercise price of $1.29 per share. F8 · derivative.exercise_date: The stock options were scheduled to fully vest on August 21, 2018, the third anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.